Skip to main content

Table 2 Cardiovascular risk profile in control and obstructive sleep apnea

From: Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease

 

Control n = 43

OSA n = 35

p

HTN n (%)

35 (81.3)

27 (77)

0.64

RRsys (mmHg)

133 ± 17

135 ± 15

0.51

RRdia (mmHg)

78 ± 11

77 ± 10

0.64

HLP, n (%)

40 (93)

34 (97)

0.82

Smoker/Ex-Smoker, n (%)

3 (6.9)/22 (51.1)

5 (14.2)/21 (60)

 

Packyears (n)

15 ± 19

22 ± 22

0.16

Diabetes mellitus, n (%)

8 (18.6)

8 (22.8)

0.64

Family History (CAD), n (%)

17 (39.5)

15 (42.8)

0.96

Number of Risk factors per patient

3.19 ± 1.03

3.05 ± 1.05

0.73

Laboratory variables

   

Total Cholesterol (mg/dl)

193 ± 41

190 ± 43

0.63

LDL Cholesterol (mg/dl)

126 ± 38

120 ± 31

0.40

HDL Cholesterol (mg/dl)

52 ± 20

49 ± 12

0.51

LDL/HDL

2.8 ± 1.3

3.1 ± 4.0

0.66